Literature DB >> 288394

Drug compliance in outpatients with rheumatoid arthritis.

P Lee, L J Tan.   

Abstract

A study of drug compliance was carried out on 108 patients with rheumatoid arthritis. Thirty-nine per cent were non-compliant with their antirheumatic medication, varying from occasional to complete failure to take the prescribed drugs. Compared with those taking their medication regularly, the non-compliant patients had a significantly lower mean active joint count and average pain severity and a significantly higher proportion had not received an adequate explanation of their disease. However, drug default does not appear to be a significant problem in management of rheumatoid arthritis, as over 90% of patients were taking their medications all or most of the time. Patients with this disease appear motivated to taking their medication regularly by the presence of chronic and often severe pain.

Entities:  

Mesh:

Year:  1979        PMID: 288394     DOI: 10.1111/j.1445-5994.1979.tb04138.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  9 in total

1.  Articular damage in late rheumatoid arthritis.

Authors:  Emel Eksioglu; Reyhan Tuncay; Eda Gurcay; Ajda Bal; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2006-04-22       Impact factor: 2.980

2.  A review of non-steroidal anti-inflammatory drugs.

Authors:  D Rosenbloom; M A Craven
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

3.  Factors affecting drug treatment compliance in patients with rheumatoid arthritis.

Authors:  Reyhan Tuncay; Emel Eksioglu; Banu Cakir; Eda Gurcay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2007-01-11       Impact factor: 2.631

4.  Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis.

Authors:  H L Brus; M A van de Laar; E Taal; J J Rasker; O Wiegman
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

5.  Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Araceli Garcia-Gonzalez; Marsha Richardson; Maria Garcia Popa-Lisseanu; Vanessa Cox; Michael A Kallen; Namieta Janssen; Bernard Ng; Donald M Marcus; John D Reveille; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2008-01-08       Impact factor: 2.980

Review 6.  Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Lin Li; Yafei Cui; Rulan Yin; Shengnan Chen; Qian Zhao; Haoyang Chen; Biyu Shen
Journal:  Patient Prefer Adherence       Date:  2017-08-04       Impact factor: 2.711

7.  Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis.

Authors:  Irazú Contreras-Yáñez; Guillermo Arturo Guaracha-Basáñez; Maximiliano Cuevas-Montoya; José de Jesús Hernández-Bautista; Virginia Pascual-Ramos
Journal:  Arthritis Res Ther       Date:  2022-08-12       Impact factor: 5.606

8.  Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability.

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Antonio R Villa; Javier Cabiedes; Marina Rull-Gabayet
Journal:  Arthritis Res Ther       Date:  2009-02-19       Impact factor: 5.156

9.  Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective.

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.